Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • ascls.org
    • ascls.org

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society for Clinical Laboratory Science
  • ascls.org
    • ascls.org
  • My alerts
  • Log in
  • My Cart
American Society for Clinical Laboratory Science

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • Follow ASCLS on Twitter
  • Visit ASCLS on Facebook
  • Follow ASCLS on Instagram
  • RSS Feed
Research ArticleFocus: Hemorrhagic Platelet Disorders

Thrombocytopenia

Larry D Brace
American Society for Clinical Laboratory Science January 2007, 20 (1) 38-47; DOI: https://doi.org/10.29074/ascls.20.1.38
Larry D Brace
is Associate Professor Emeritus, University of Illinois at Chicago, Chicago IL
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lbrace@uic.edu
  • Article
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

  1. Larry D Brace, PhD⇑
    1. is Associate Professor Emeritus, University of Illinois at Chicago, Chicago IL
  1. Address for correspondence: Larry Brace PhD, Professor Emeritus, University of Illinois at Chicago, 11285 Plainfield Road, Indian Head Park IL 60525. (708) 246-7150. lbrace{at}uic.edu.

Upon completion of this article, the reader will be able to:

  1. list the inherited forms of thrombocytopenia and distinguish disorders of production from disorders of consumption.

  2. recall the hallmark laboratory findings of chronic and acute immune thrombocytopenia purpura.

  3. test for heparin-induced thrombocytopenia with thrombosis.

  4. distinguish thrombocytopenia-induced mucocutaneous bleeding from anatomic bleeding.

  5. describe the mechanism of drug-induced thrombocytopenia and the means for its detection and cure.

  6. distinguish between thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome.

Extract

Thrombocytopenia is a decrease in circulating platelet count. The typical reference range is approximately 150,000 to 450,000/μL. Thrombocytopenia (platelet count <150,000/μL) is the most common cause of mucocutaneous bleeding, characterized by petechiae, purpura, ecchymoses, epistaxis, hematemesis, and menorrhagia. The primary pathophysiologic processes in thrombocytopenia are decreased platelet production, accelerated platelet destruction, and abnormal platelet distribution or sequestration (Table 1).

It is unusual for bleeding to occur when the platelet count is greater than 50,000/μL, and patients with platelet counts of 20,000/μL may have few bleeding symptoms. Patients with platelet counts less than 10,000/μL are at high risk for a serious spontaneous hemorrhagic episode.

Congenital megakaryocytic hypoplasia Megakaryocytic hypoplasia (decrease in bone marrow megakaryocytes) is seen in thrombocytopenia with absent radii (TAR), Wiskott-Aldrich syndrome, Bernard-Soulier syndrome, and May-Hegglin anomaly. Although thrombocytopenia is a feature of Bernard-Soulier syndrome and Wiskott-Aldrich syndrome, the primary abnormality is qualitative so these are discussed separately.

May-Hegglin anomaly is a rare autosomal dominant disorder whose exact frequency is unknown. Platelets are 20 μm in diameter and Döhle bodies are present in neutrophils (Figure 1). Other than their increased diameter, platelet morphology is normal. Thrombocytopenia is present in about one third to one half of patients. Platelet function in response to platelet activating agents is normal. In some patients, megakaryocytes are increased in number and have abnormal ultrastructure. A mutation in the MYH9 gene that encodes for non-muscle myosin heavy chain, a cytoskeletal protein in platelets, may be responsible for the abnormal platelet diameter.1-3 Most…

ABBREVIATIONS: DIC = disseminated intravascular coagulation; HELLP syndrome = microangiopathic hemolysis, elevated liver enzymes, and a low platelet count; HIT = heparin-induced thrombocytopenia; HUS = hemolyticuremic syndrome; HUS = hemolytic-uremic syndrome; ITP = immune thrombocytopenic purpura; PF4 = platelet factor 4; TAR = thrombocytopenia with absent radii; TTP = thrombotic thrombocytopenic purpura; ULVWF = unusually large von Willebrand factor; VWF = von Willebrand factor.

    INDEX TERMS
  • platelets
  • immune thrombocytopenic purpura
  • thrombocytopenia

Upon completion of this article, the reader will be able to:

  1. list the inherited forms of thrombocytopenia and distinguish disorders of production from disorders of consumption.

  2. recall the hallmark laboratory findings of chronic and acute immune thrombocytopenia purpura.

  3. test for heparin-induced thrombocytopenia with thrombosis.

  4. distinguish thrombocytopenia-induced mucocutaneous bleeding from anatomic bleeding.

  5. describe the mechanism of drug-induced thrombocytopenia and the means for its detection and cure.

  6. distinguish between thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome.

  • © Copyright 2007 American Society for Clinical Laboratory Science Inc. All rights reserved.
PreviousNext
Back to top

In this issue

American Society for Clinical Laboratory Science: 20 (1)
American Society for Clinical Laboratory Science
Vol. 20, Issue 1
Winter 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Society for Clinical Laboratory Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Thrombocytopenia
(Your Name) has sent you a message from American Society for Clinical Laboratory Science
(Your Name) thought you would like to see the American Society for Clinical Laboratory Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Thrombocytopenia
Larry D Brace
American Society for Clinical Laboratory Science Jan 2007, 20 (1) 38-47; DOI: 10.29074/ascls.20.1.38

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Thrombocytopenia
Larry D Brace
American Society for Clinical Laboratory Science Jan 2007, 20 (1) 38-47; DOI: 10.29074/ascls.20.1.38
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Platelet Function Testing: Aggregometry and Lumiaggregometry
  • Qualitative Platelet Disorders
Show more Focus: Hemorrhagic Platelet Disorders

Similar Articles

Keywords

  • platelets
  • immune thrombocytopenic purpura
  • Thrombocytopenia

© 2025 The American Society for Clinical Laboratory Science

Powered by HighWire